Southpoint Capital Advisors LP
10% Owner
- 2025
- Dec 29, 2025
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Southpoint Capital Advisors LP files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Robert Andrade - $884K in FENC purchases and sales in the last 12 months
- Rosty Raykov - $790K in FENC purchases and sales in the last 12 months
- Marco Maria Brughera - $160K in FENC purchases and sales in the last 12 months
- Pierre Sargis Sayad - $146K in FENC purchases and sales in the last 12 months
- Chris A. Rallis - $59K in FENC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Southpoint Capital Advisors LP?
Southpoint Capital Advisors LP is an investment firm, tracked as 10% Owner of FENNEC PHARMACEUTICALS INC. (FENC). InsiderAlpha holds 4 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Southpoint Capital Advisors LP last file a Form 4?
The most recent primary Form 4 on record is dated 29 December 2025, one of 4 filings going back to 2025.
Has Southpoint Capital Advisors LP been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($10.34M) across all tracked filings.
